Home Blog Page 128

Blog

Pharma Marketing Blog

Most popular

Equation Proves that Broadcast DTCA Only a Minor Contributor to Growth...

Pharma Guy - May 17, 2010

FDA DTC Payola Out, You Pay In!

Pharma Guy - January 10, 2008

Merck’s Goal: “One Less” Gardasil Marketing Problem

Pharma Guy - October 20, 2008

DTC Critters to Strike – Cite New Media Residuals as Issue

Pharma Guy - December 10, 2007

Adventures of PhRMA Intern!

Pharma Guy - July 12, 2006

So Far, I Have Donated More to Haiti Relief Than Pharma...

Pharma Guy - January 18, 2010

Free CME Without Direct Pharma Support: Is It Possible?

Pharma Guy - June 15, 2007

CGC: Old Wine in New Bottles

Pharma Guy - October 23, 2006

Pharma Profits on Slippery Slope?

Pharma Guy - January 21, 2005

5 Reasons Why I Follow Martin Shkreli on Twitter

Pharma Guy - October 19, 2015

1...127128129...240 Page 128 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026